![Kawasaki disease: guidelines of Italian Society of Pediatrics, part II - treatment of resistant forms and cardiovascular complications, follow-up, lifestyle and prevention of cardiovascular risks | Italian Journal of Pediatrics | Full Text Kawasaki disease: guidelines of Italian Society of Pediatrics, part II - treatment of resistant forms and cardiovascular complications, follow-up, lifestyle and prevention of cardiovascular risks | Italian Journal of Pediatrics | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13052-018-0529-2/MediaObjects/13052_2018_529_Fig1_HTML.png)
Kawasaki disease: guidelines of Italian Society of Pediatrics, part II - treatment of resistant forms and cardiovascular complications, follow-up, lifestyle and prevention of cardiovascular risks | Italian Journal of Pediatrics | Full Text
![Pharmacologic interventions for Kawasaki disease in children: A network meta-analysis of 56 randomized controlled trials - eBioMedicine Pharmacologic interventions for Kawasaki disease in children: A network meta-analysis of 56 randomized controlled trials - eBioMedicine](https://www.thelancet.com/cms/asset/ecb82b7e-122e-42dd-81e4-527761cd8a3c/gr1.jpg)
Pharmacologic interventions for Kawasaki disease in children: A network meta-analysis of 56 randomized controlled trials - eBioMedicine
High-Dose Aspirin Is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki Disease | PLOS ONE
![Dr Joshua Walinjom on X: "Kawasaki disease Management: high-dose aspirin intravenous immunoglobulin echocardiogram ? coronary artery aneurysms https://t.co/L53EhKXnHE" / X Dr Joshua Walinjom on X: "Kawasaki disease Management: high-dose aspirin intravenous immunoglobulin echocardiogram ? coronary artery aneurysms https://t.co/L53EhKXnHE" / X](https://pbs.twimg.com/media/F0m_AVIXsAIsTX6.jpg)
Dr Joshua Walinjom on X: "Kawasaki disease Management: high-dose aspirin intravenous immunoglobulin echocardiogram ? coronary artery aneurysms https://t.co/L53EhKXnHE" / X
![Treat acute Kawasaki disease with aspirin plus intravenous immunoglobulin to improve coronary outcomes | SpringerLink Treat acute Kawasaki disease with aspirin plus intravenous immunoglobulin to improve coronary outcomes | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2FBF03262128/MediaObjects/40267_2012_2128_FigU1.jpg)
Treat acute Kawasaki disease with aspirin plus intravenous immunoglobulin to improve coronary outcomes | SpringerLink
![Revised recommendations of the Italian Society of Pediatrics about the general management of Kawasaki disease | Italian Journal of Pediatrics | Full Text Revised recommendations of the Italian Society of Pediatrics about the general management of Kawasaki disease | Italian Journal of Pediatrics | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13052-021-00962-4/MediaObjects/13052_2021_962_Fig2_HTML.png)
Revised recommendations of the Italian Society of Pediatrics about the general management of Kawasaki disease | Italian Journal of Pediatrics | Full Text
![Frontiers | Aspirin Dose and Treatment Outcomes in Kawasaki Disease: A Historical Control Study in Japan Frontiers | Aspirin Dose and Treatment Outcomes in Kawasaki Disease: A Historical Control Study in Japan](https://www.frontiersin.org/files/Articles/522921/fped-08-00249-HTML-r1/image_m/fped-08-00249-t002.jpg)
Frontiers | Aspirin Dose and Treatment Outcomes in Kawasaki Disease: A Historical Control Study in Japan
![Current pharmacological intervention and development of targeting IVIG resistance in Kawasaki disease. - Abstract - Europe PMC Current pharmacological intervention and development of targeting IVIG resistance in Kawasaki disease. - Abstract - Europe PMC](https://europepmc.org/articles/PMC7500898/bin/gr1_lrg.jpg)